--- title: "REACH Study: Real-world Evidence to Advance Multi-Cancer Early Detection Health Equity | Sutter Health" description: "REACH Study: Real-world Evidence to Advance Multi-Cancer Early Detection Health Equity" url: "https://www.sutterhealth.org/research/clinical-trials/reach-study-real-world-evidence-to-advance-multi-cancer-early-detection-health-equity-1097318869" --- 1. [Home](https://www.sutterhealth.org/) / 2. [Research](https://www.sutterhealth.org/research) / 3. [Clinical trials](https://www.sutterhealth.org/research/clinical-trials) / 4. REACH Study: Real-world Evidence to Advance Multi-Cancer Early Detection Health Equity # Cancer Early Detection REACH **Status:** Open to Enrollment [Email us to enroll](https://www.sutterhealth.org/research/clinical-trials/reach-study-real-world-evidence-to-advance-multi-cancer-early-detection-health-equity-1097318869#enroll) #### Study details View study details on [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT05673018). #### Locations - Sacramento - Palo Alto - Roseville - Davis - Elk Grove - Santa Rosa - Fairfield - Auburn - Modesto - Sunnyvale - Santa Cruz #### Clinical trial FAQs Information for patients and study volunteers, including [frequently asked questions](https://www.sutterhealth.org/research/faqs). This multi-center comparative prospective cohort study is designed to assess the real world clinical impact, including safety and test performance, of Galleri®, a blood-based multi-cancer early detection (MCED) test. The study will seek to enroll approximately 20% of the study participants from under-represented minority populations (e.g., racial / ethnic minority groups, socioeconomically disadvantaged populations, rural populations). ![Charles H McDonnell, III, M.D., FACR](https://dyn.mktgcdn.com/p/Fu1nS5Z32gezAI_DgX0neqVVepZCmXpLjwBiPkTMEko/fit=crop,gravity=auto,dpr=2,width=188,height=250,quality=100) Charles H McDonnell, III, M.D., FACR Principal investigator [View profile](https://www.sutterhealth.org/research/investigators/charles-h-mcdonnell-iii-md-facr-1049681108) ![Natalia Colocci, M.D., Ph.D.](https://dyn.mktgcdn.com/p/VWRHn-FhVXyOQoH9mE4avetDV2Vu6LSi7TvVK9zi54c/fit=crop,gravity=auto,dpr=2,width=188,height=250,quality=100) Natalia Colocci, M.D., Ph.D. Principal investigator [View profile](https://www.sutterhealth.org/research/investigators/natalia-colocci-md-phd-1049680997) ## Email us to enroll - [Email Sacramento](mailto:ClinicalResearch%40sutterhealth.org?subject=More%20information%20on%20Cancer%20Early%20Detection%20REACH%20in%20Sacramento&body=Please%20be%20aware%20that%20if%20you%20reply%20with%20unencrypted%20email%2C%20this%20increases%20the%20risk%20that%20information%20could%20be%20read%20by%20an%20unauthorized%20third%20party.%20Please%20do%20not%20include%20any%20Protected%20Health%20Information%20in%20your%20email%20response.) - [Email Palo Alto](mailto:ClinicalResearch%40sutterhealth.org?subject=More%20information%20on%20Cancer%20Early%20Detection%20REACH%20in%20Palo%20Alto&body=Please%20be%20aware%20that%20if%20you%20reply%20with%20unencrypted%20email%2C%20this%20increases%20the%20risk%20that%20information%20could%20be%20read%20by%20an%20unauthorized%20third%20party.%20Please%20do%20not%20include%20any%20Protected%20Health%20Information%20in%20your%20email%20response.) - [Email Roseville](mailto:ClinicalResearch%40sutterhealth.org?subject=More%20information%20on%20Cancer%20Early%20Detection%20REACH%20in%20Roseville&body=Please%20be%20aware%20that%20if%20you%20reply%20with%20unencrypted%20email%2C%20this%20increases%20the%20risk%20that%20information%20could%20be%20read%20by%20an%20unauthorized%20third%20party.%20Please%20do%20not%20include%20any%20Protected%20Health%20Information%20in%20your%20email%20response.) - [Email Davis](mailto:ClinicalResearch%40sutterhealth.org?subject=More%20information%20on%20Cancer%20Early%20Detection%20REACH%20in%20Davis&body=Please%20be%20aware%20that%20if%20you%20reply%20with%20unencrypted%20email%2C%20this%20increases%20the%20risk%20that%20information%20could%20be%20read%20by%20an%20unauthorized%20third%20party.%20Please%20do%20not%20include%20any%20Protected%20Health%20Information%20in%20your%20email%20response.) - [Email Elk Grove](mailto:ClinicalResearch%40sutterhealth.org?subject=More%20information%20on%20Cancer%20Early%20Detection%20REACH%20in%20Elk%20Grove&body=Please%20be%20aware%20that%20if%20you%20reply%20with%20unencrypted%20email%2C%20this%20increases%20the%20risk%20that%20information%20could%20be%20read%20by%20an%20unauthorized%20third%20party.%20Please%20do%20not%20include%20any%20Protected%20Health%20Information%20in%20your%20email%20response.) - [Email Santa Rosa](mailto:ClinicalResearch%40sutterhealth.org?subject=More%20information%20on%20Cancer%20Early%20Detection%20REACH%20in%20Santa%20Rosa&body=Please%20be%20aware%20that%20if%20you%20reply%20with%20unencrypted%20email%2C%20this%20increases%20the%20risk%20that%20information%20could%20be%20read%20by%20an%20unauthorized%20third%20party.%20Please%20do%20not%20include%20any%20Protected%20Health%20Information%20in%20your%20email%20response.) - [Email Fairfield](mailto:ClinicalResearch%40sutterhealth.org?subject=More%20information%20on%20Cancer%20Early%20Detection%20REACH%20in%20Fairfield&body=Please%20be%20aware%20that%20if%20you%20reply%20with%20unencrypted%20email%2C%20this%20increases%20the%20risk%20that%20information%20could%20be%20read%20by%20an%20unauthorized%20third%20party.%20Please%20do%20not%20include%20any%20Protected%20Health%20Information%20in%20your%20email%20response.) - [Email Auburn](mailto:ClinicalResearch%40sutterhealth.org?subject=More%20information%20on%20Cancer%20Early%20Detection%20REACH%20in%20Auburn&body=Please%20be%20aware%20that%20if%20you%20reply%20with%20unencrypted%20email%2C%20this%20increases%20the%20risk%20that%20information%20could%20be%20read%20by%20an%20unauthorized%20third%20party.%20Please%20do%20not%20include%20any%20Protected%20Health%20Information%20in%20your%20email%20response.) - [Email Modesto](mailto:ClinicalResearch%40sutterhealth.org?subject=More%20information%20on%20Cancer%20Early%20Detection%20REACH%20in%20Modesto&body=Please%20be%20aware%20that%20if%20you%20reply%20with%20unencrypted%20email%2C%20this%20increases%20the%20risk%20that%20information%20could%20be%20read%20by%20an%20unauthorized%20third%20party.%20Please%20do%20not%20include%20any%20Protected%20Health%20Information%20in%20your%20email%20response.) - [Email Sunnyvale](mailto:ClinicalResearch%40sutterhealth.org?subject=More%20information%20on%20Cancer%20Early%20Detection%20REACH%20in%20Sunnyvale&body=Please%20be%20aware%20that%20if%20you%20reply%20with%20unencrypted%20email%2C%20this%20increases%20the%20risk%20that%20information%20could%20be%20read%20by%20an%20unauthorized%20third%20party.%20Please%20do%20not%20include%20any%20Protected%20Health%20Information%20in%20your%20email%20response.) - [Email Santa Cruz](mailto:ClinicalResearch%40sutterhealth.org?subject=More%20information%20on%20Cancer%20Early%20Detection%20REACH%20in%20Santa%20Cruz&body=Please%20be%20aware%20that%20if%20you%20reply%20with%20unencrypted%20email%2C%20this%20increases%20the%20risk%20that%20information%20could%20be%20read%20by%20an%20unauthorized%20third%20party.%20Please%20do%20not%20include%20any%20Protected%20Health%20Information%20in%20your%20email%20response.) ## Related clinical trials [View all clinical trials](https://www.sutterhealth.org/research-search-results?verticalKey=clinical_trial) - Clinical trial ### [Advanced Cervical Cancer NRG GY037](https://www.sutterhealth.org/research/clinical-trials/advanced-cervical-cancer-nrg-gy037-2097344123) A Phase III Study of Induction Pembrolizumab and Chemotherapy Followed by Chemoradiation and Pembrolizumab vs Chemoradiation and Pembrolizumab Both Followed by Pembrolizumab for High Risk Locally Advanced Cervical Cancer **Status:** Open to Enrollment - Clinical trial ### [Advanced Staged Cancer Targeted Therapy ASCO TAPUR](https://www.sutterhealth.org/research/clinical-trials/targeted-agent-and-profiling-utilization-registry-tapur-st-1049141787) Targeted Agent and Profiling Utilization Registry (TAPUR) Study **Status:** Open to Enrollment - Clinical trial ### [Adverse Effects of Chemotherapy Shengbai Solution](https://www.sutterhealth.org/research/clinical-trials/adverse-effects-of-chemotherapy-shengbai-solution-1097505286) A Randomized, Blinded, Placebo-controlled Trial of Shengbai Oral Formula to Assess Safety and Alleviation of Adverse Effects in Patients With Cancer Undergoing Chemotherapy **Status:** Open to Enrollment - Clinical trial ### [Acute Myeloid Leukemia Dental Wipes COG ACCL2531](https://www.sutterhealth.org/research/clinical-trials/acute-myeloid-leukemia-dental-wipes-cog-accl2531-2099128841) A Randomized Double-Blinded Trial of Xylitol Dental Wipes for the Prophylaxis of Bloodstream Infections From Oral Organisms in Pediatric Patients With Acute Myeloid Leukemia **Status:** Open to Enrollment - Clinical trial ### [Adjuvant Advance Ovarian Cancer FRAmework-01 J5E-MC-JZXB](https://www.sutterhealth.org/research/clinical-trials/adjuvant-advance-ovarian-cancer-framework-01-j5e-mc-jzxb-2066913418) FRAmework-01: A Two-Part Phase 3 Study of Sofetabart Mipitecan (LY4170156) Versus Chemotherapy or Mirvetuximab Soravtansine in Platinum-Resistant Ovarian Cancer, and Sofetabart Mipitecan Plus Bevacizumab Versus Platinum-Based Chemotherapy Plus Bevacizumab in Platinum-Sensitive Ovarian Cancer. **Status:** Open to Enrollment [View all clinical trials](https://www.sutterhealth.org/research-search-results?verticalKey=clinical_trial) ```json {"@context":"https://schema.org","@type":"MedicalOrganization","name":"Sutter Health","@id":"https://www.sutterhealth.org/#medicalorganization","url":"https://www.sutterhealth.org","logo":"https://www.sutterhealth.org/static/images/sutter-health-logo.svg","address":{"@type":"PostalAddress","streetAddress":"2200 River Plaza Drive","addressLocality":"Sacramento","addressRegion":"CA","postalCode":"95833","addressCountry":"US"},"areaServed":{"@type":"AdministrativeArea","name":"California"},"sameAs":["https://www.facebook.com/SutterHealth","https://www.instagram.com/sutterhealth/","https://x.com/SutterHealth","https://www.youtube.com/sutterhealth","https://www.linkedin.com/company/sutter-health","https://en.wikipedia.org/wiki/Sutter_Health"]} ``` ```json {"@context":"https://schema.org","@type":"BreadcrumbList","@id":"https://www.sutterhealth.org/research/clinical-trials/reach-study-real-world-evidence-to-advance-multi-cancer-early-detection-health-equity-1097318869#breadcrumblist","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https://www.sutterhealth.org/"},{"@type":"ListItem","position":2,"name":"Research","item":"https://www.sutterhealth.org/research"},{"@type":"ListItem","position":3,"name":"Clinical trials","item":"https://www.sutterhealth.org/research/clinical-trials"},{"@type":"ListItem","position":4,"name":"REACH Study: Real-world Evidence to Advance Multi-Cancer Early Detection Health Equity"}]} ``` ```json {"@context":"https://schema.org","@type":"MedicalWebPage","@id":"https://www.sutterhealth.org/research/clinical-trials/reach-study-real-world-evidence-to-advance-multi-cancer-early-detection-health-equity-1097318869#medicalwebpage","name":"Cancer Early Detection REACH","description":"REACH Study: Real-world Evidence to Advance Multi-Cancer Early Detection Health Equity","url":"https://www.sutterhealth.org/research/clinical-trials/reach-study-real-world-evidence-to-advance-multi-cancer-early-detection-health-equity-1097318869","inLanguage":"en-US","dateModified":"2026-07-07","publisher":{"@type":"MedicalOrganization","name":"Sutter Health","@id":"https://www.sutterhealth.org/#medicalorganization","url":"https://www.sutterhealth.org"},"medicalAudience":{"@type":"MedicalAudience","audienceType":"Patient"},"mainEntity":{"@id":"https://www.sutterhealth.org/research/clinical-trials/reach-study-real-world-evidence-to-advance-multi-cancer-early-detection-health-equity-1097318869#medicaltrial"},"breadcrumb":{"@id":"https://www.sutterhealth.org/research/clinical-trials/reach-study-real-world-evidence-to-advance-multi-cancer-early-detection-health-equity-1097318869#breadcrumblist"},"mentions":[{"@type":"Person","name":"Charles H McDonnell, III, M.D., FACR","url":"https://www.sutterhealth.org/research/investigators/charles-h-mcdonnell-iii-md-facr-1049681108","jobTitle":"Principal Investigator","affiliation":{"@type":"MedicalOrganization","name":"Sutter Health","@id":"https://www.sutterhealth.org/#medicalorganization","url":"https://www.sutterhealth.org"}},{"@type":"Person","name":"Natalia Colocci, M.D., Ph.D.","url":"https://www.sutterhealth.org/research/investigators/natalia-colocci-md-phd-1049680997","jobTitle":"Principal Investigator","affiliation":{"@type":"MedicalOrganization","name":"Sutter Health","@id":"https://www.sutterhealth.org/#medicalorganization","url":"https://www.sutterhealth.org"}}]} ``` ```json {"@context":"https://schema.org","@type":"MedicalTrial","@id":"https://www.sutterhealth.org/research/clinical-trials/reach-study-real-world-evidence-to-advance-multi-cancer-early-detection-health-equity-1097318869#medicaltrial","name":"Cancer Early Detection REACH","alternateName":"REACH Study: Real-world Evidence to Advance Multi-Cancer Early Detection Health Equity","url":"https://www.sutterhealth.org/research/clinical-trials/reach-study-real-world-evidence-to-advance-multi-cancer-early-detection-health-equity-1097318869","description":"This multi-center comparative prospective cohort study is designed to assess the real world clinical impact, including safety and test performance, of Galleri®, a blood-based multi-cancer early detection (MCED) test. The study will seek to enroll approximately 20% of the study participants from under-represented minority populations (e.g., racial / ethnic minority groups, socioeconomically disadvantaged populations, rural populations).","identifier":"NCT05673018","code":{"@type":"MedicalCode","codeValue":"NCT05673018","codingSystem":"ClinicalTrials.gov"},"sameAs":"https://clinicaltrials.gov/study/NCT05673018","status":"https://schema.org/Recruiting","studyLocation":[{"@type":"AdministrativeArea","name":"Sacramento"},{"@type":"AdministrativeArea","name":"Palo Alto"},{"@type":"AdministrativeArea","name":"Roseville"},{"@type":"AdministrativeArea","name":"Davis"},{"@type":"AdministrativeArea","name":"Elk Grove"},{"@type":"AdministrativeArea","name":"Santa Rosa"},{"@type":"AdministrativeArea","name":"Fairfield"},{"@type":"AdministrativeArea","name":"Auburn"},{"@type":"AdministrativeArea","name":"Modesto"},{"@type":"AdministrativeArea","name":"Sunnyvale"},{"@type":"AdministrativeArea","name":"Santa Cruz"}]} ```